$14.50 -0.75 (-4.92%)

Green Dot Corporation (GDOT)

Green Dot Corporation is a financial technology and bank holding company that offers prepaid debit card products and financial services. Founded in 1999, the company provides banking solutions aimed at underserved and underserved populations, including reloadable prepaid cards, mobile banking, and small business banking services. Green Dot is known for its innovative approach to payments and digital banking, partnering with various retailers, fintech firms, and corporations to expand access to financial services.

🚫 Green Dot Corporation does not pay dividends

Company News

Best Personal Loans for Bad Credit Guaranteed Approval Direct Lenders up to $5000 No Credit Check - Payday Ventures
GlobeNewswire Inc. • Payday Ventures • May 22, 2025

Payday Ventures, a leading provider of online loans, operates platforms offering fast and flexible personal loans for bad credit with guaranteed approval. These loans are designed for people with less-than-perfect credit who need quick access to financing for emergencies, car repairs, or other expenses.

Why You Should Retain Green Dot Stock in Your Portfolio for Now
Benzinga • Zacks • September 20, 2024

Green Dot is focusing on long-term growth through prepaid cards and Banking-as-a-Service partnerships, despite facing challenges like decreasing customers and partnership losses. The company has a strong balance sheet with no debt, but does not pay dividends.

Here's Why You Should Hold Green Dot (GDOT) Stock for Now
Zacks Investment Research • Zacks Equity Research • June 28, 2024

GO2bank will be the key driver of Green Dot's (GDOT) revenues going forward.

Why Green Dot Stock Plunged Today
The Motley Fool • [email protected] (Jeremy Bowman) • November 10, 2023

The fintech's profits tumbled in its third quarter as purchase volumes fell.

Omicron-targeting COVID boosters expected this week, but experts are worried there may be low uptake
MarketWatch • MarketWatch • August 29, 2022

The Food and Drug Administration is expected to authorize new COVID-19 booster shots this week that target the latest versions of the omicron variant but will do so without data from a study showing the shots were safe and worked in humans.

Related Companies